Performance Medical Technologies - Business

Restore mitochondrial function, slash $17k/year costs, and boost neuroprotection backed by Phase 2 trials and $40B market potential!

Problem

Emerging medical therapies for neurodegenerative diseases are often difficult for patients, providers, and investors to understand. Patients need simple education, providers need secure clinical data and treatment support, while investors need clear insight into clinical progress, regulatory direction, market opportunity, and partnership potential.

Solution

Designed PMT as a professional medical technology platform that clearly presents IV NAD+ therapy research, Parkinson’s Disease treatment focus, provider services, patient education, clinical innovation, investor opportunities, regulatory progress, and newsletter updates in one structured digital experience.